对话分析
宏观分析
个别股票
Alpha 实验室
实用工具
Menu
ZH
登录
ZH
暴涨分析
/
Rallybio Corporation
/
2026-05-04
▲ SURGE
Rallybio Corporation
+50.1%
RLYB
NASDAQ
Healthcare
2026-05-04
14.12
收盘价
9.41
前收盘价
+50.05%
涨幅
150.2x
量比
暴涨原因
没有相关新闻。
相关新闻
ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Feder
Gurufocus
2026-04-29
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
Tipranks
2026-03-19
ImmunityBio, Inc. (26CA.F) stock price, news, quote and history
Au.Finance.Yahoo
2026-04-26
Eli Lilly’s LY3537031 Renal Study Moves Forward, Shaping Early Pipeline Expectations
Tipranks
2026-04-25
Roundtable CEO James Heckman Details NASDAQ Strategy, Long-Term Focus, Capitalization Structure, and Lock-Up
Thestreet
2026-04-06
技术分析
没有技术分析数据。
查看股票详情
返回暴涨股列表
Rallybio Corporation +50.1% 暴涨分析 (2026-05-04) | Alpha Lenz